Zimmer Holdings Inc (ZMH)
ZMH (NYSE:Health Services)
$79.95
+0.09
+0.11%
Today's Range: 79.26 - 80.00 |
ZMH Avg Daily Volume: 1,033,400
| Last Update: 05/23/13 - 4:03 PM EDT |
| Volume: 778,320 |
| YTD Performance: 19.80%
|
| Open: $79.35 |
| Previous Close: $79.86 |
| 52 Week Range: $57.46 -
$81.92 |
| Oustanding Shares: 168,363,805 |
| Market Cap: 13,639,151,843 |
6-Month Chart
TheStreet Ratings Grade for ZMH
| Buy |
Hold
|
Sell
|
| A+ |
A |
A- |
B+ |
B |
B- |
C+ |
C |
C- |
D+ |
D |
D- |
E+ |
E |
E- |
F |
Analysts Ratings
| Historical Rec |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
| Strong Buy |
11 |
12 |
12 |
12 |
| Moderate Buy |
0 |
0 |
0 |
0 |
| Hold |
13 |
15 |
15 |
15 |
| Moderate Sell |
0 |
0 |
0 |
0 |
| Strong Sell |
1 |
0 |
0 |
0 |
| Mean Rec. |
2.20 |
2.11 |
2.11 |
2.11 |
| Latest Dividend: |
0.20 |
| Latest Dividend Yield: |
0.99% |
| Dividend Ex-Date: |
03/26/13 |
| Price Earnings Ratio: |
18.41 |
|
| Price Earnings Comparisons: |
| ZMH |
Sector Avg. |
S&P 500 |
| 18.41 |
18.40 |
17.70 |
| Price Performance History (%Change): |
| 3 Mo |
1 Yr |
3 Y |
|
7.72%
|
32.79%
|
43.04%
|
|
| GROWTH |
12 Mo |
3 Yr |
CAGR |
| Revenue |
0.40 |
0.09 |
0.03 |
| Net Income |
0.00 |
0.00 |
0.00 |
| EPS |
6.50 |
0.29 |
0.09 |
| Earnings for ZMH: |
| EBITDA |
1.66B |
| Revenue |
4.47B |
|
Average Earnings Estimates
;Qtr (09/13);FY (12/13);FY (12/14)&HEADING_LIST1=Qtr (06/12);Qtr (09/12);FY (12/12);FY (12/13)) |
|
| Average Estimate |
$1.44 |
$1.26 |
$5.76 |
$6.25 |
| Number of Analysts |
15 |
15 |
20 |
18 |
| High Estimate |
$1.48 |
$1.30 |
$5.85 |
$6.39 |
| Low Estimate |
$1.42 |
$1.21 |
$5.65 |
$5.89 |
| Prior Year |
$1.34 |
$1.15 |
$5.30 |
$5.76 |
| Growth Rate (Year over Year) |
7.61% |
9.91% |
8.63% |
8.49% |
| Feb 26, 2013 | 2:45 PM EST
Two domestic exploration and production names that scream 'buy me' are Devon and Southwestern.
| Feb 22, 2013 | 9:05 AM EST
Some thoughts on M&A implications and possible candidates.
Feb 01, 2013 | 6:35 AM EST
ZMH was downgraded from Buy to Underperform, Mizuho said. Near-term expectations remain too high.
Jan 25, 2013 | 7:19 AM EST
Shares of ZMH now seen reaching $79, according to Credit Suisse. Estimates also increased, given higher expected knee growth. Neutral r...
Jan 14, 2013 | 8:46 AM EST
ZMH was downgraded from Buy to Neutral, Lazard Capital Markets said. Valuation call.
| Dec 26, 2012 | 10:00 AM EST
After a multiyear hiatus, M&A activity is set to rebound in 2013.
Oct 12, 2012 | 8:01 AM EDT
ZMH was initiated with an Outperform rating, JMP Securities said. $76 price target. Industry has several favorable tailwinds.
| Oct 09, 2012 | 11:00 AM EDT
A look at the different sectors that will be affected by a reelection.
Sep 07, 2012 | 7:53 AM EDT
ZMH was upgraded from Market Perform to Outperform, Bernstein said. Valuation call, based on a $76 price target.
Sep 04, 2012 | 7:35 AM EDT
Shares of ZMH now seen reaching $72, according to Bank of America/Merrill Lynch said. Growth should accelerate in 2013. Buy rating.&nbs...
